Skip to content

"A study to assess the effectiveness of chewing gum on reducing oral mucositis and quality of life in patient receiving chemotherapy."

ââ?¬Å?ââ?¬â?¹ A Randomized controlled Trial to assess the effectiveness of chewing gum on reducing incidence and severity of chemotherapy induced oral mucositis and quality of life among patient receiving conventional mucotoxic chemotherapy.ââ?¬â?¹ ââ?¬?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033616
Enrollment
90
Registered
2021-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: sugar free chewing gum: sugar free chewing gum 1 x QID for 21 days will be given to the intervention group long with conventional therapy. Control Intervention1: sugar free chewing 1 x

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Adult patient of age 18yrs or more 2 Patients receiving conventional mucotoxic chemotherapeutic agents(such as Taxane group-Paclitaxel/Docetaxel Antimetabolites-5FU Methotrexate Cytarabine Anthracycline-Doxorubicin Alkylating agents-Cyclophosphamide 3 All new patients going for 1st cycle of conventional mucotoxic chemotherapy 4 Patient with controlled comorbidities 5 Patients with who are able to chew 6 Patients who are able to understand Hindi/English

Exclusion criteria

Exclusion criteria: 1.Baseline NG tube. 2.Evidence of baseline infection. 3.Patients who are unable to chew. 4.Patients who are unable to understand Hindi/English.

Design outcomes

Primary

MeasureTime frame
Reduction in incidence and severity of oral Mucositis after administration of chewing Gum.Timepoint: At baseline and 7th day At baseline and 14th day At baseline and 21st day

Secondary

MeasureTime frame
Improvement in quality of life of patients.Timepoint: Day 0,7th, 14th and 21st.

Countries

India

Contacts

Public ContactMrs Aditi P Sinha

AIIMS, New Delhi

drrajapramanik@gmail.com9711555063

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026